Chemokine axes CXCL12/CXCR4 and CXCL16/CXCR6 correlate with lymph node metastasis in epithelial ovarian carcinoma

Chinese Journal of Cancer

Volumn 30, Issue 5, 2011, Pages 336-343

  Guo, Li ^a   Cui, Zhu Mei ^a   Zhang, Jia ^a   Huang, Yu ^a  

^a QINGDAO UNIVERSITY   (China)

Author keywords

Chemokine; CXCL12; CXCL16; Epithelial ovarian carcinoma

Indexed keywords

CHEMOKINE RECEPTOR CXCR4; CHEMOKINE RECEPTOR CXCR6; CXCL16 CHEMOKINE; STROMAL CELL DERIVED FACTOR 1;

ADULT; AGE; ARTICLE; ASCITES; BENIGN TUMOR; CANCER CLASSIFICATION; CANCER GRADING; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; OVARY CARCINOMA; OVARY TUMOR; PROGNOSIS; PROTEIN EXPRESSION; SURVIVAL TIME; TISSUE MICROARRAY;

EID: 79958158656     PISSN: 1000467X     EISSN: 1944446X     Source Type: Journal    
DOI: 10.5732/cjc.010.10490     Document Type: Article

References (16)

1. Murdoch C. CXCR4: chemokine receptor extraordinaire [J]. Immunol Rev, 2000,177:175-184.
2. Matloubian M, David A, Engel S, et al. A transmembrane CXC chemokine is a ligand for HIV-coreceptor Bonzo [J]. Nat Immunol, 2000,1: 298-304.
3. Hundhausen C, Schulte A, Schulz B, et al. Regulated shedding of transmembrane chemokines by the disintegrin and metalloproteinase 10 facilitates detachment of adherent leukocytes [J]. J Immunol, 2007,178(12):8064.
4. Darash-Yahana M, Gillespie JW, Hewitt SM, et al. The chemokine CXCL16 and its receptor, CXCR6, as markers and promoters of inflammation-as sociated cancers [J]. Plos One, 2009,4(8):e6695.
5. Le Y, Zhou Y, Iribarren P, et al. Chemokines and chemokine receptors: their manifold roles in homeostasis and disease [J]. Cell Mol Immunol, 2004,1(2):95-104.
6. Wang YS, Yang XS, Yang DL. Progress of CXCLl2 and its receptor CXC4 in urinary tract tumors [J]. Medical Recapitulate, 2010,16(20):3072-3074. [in Chinese]
7. Iwasa S, Yanagawa T, Fan J, et al. Expression of CXCR4 and its ligand SDF-1 in intestinal-type gastric cancer is associated with lymph node and liver metastasis [J]. Anticancer Res, 2009,29(11):4751.
8. Jiang YP, Wu XH, Wu WX, et al. Expressions of chemokine CXCL12 and its receptor CXCR4 and the clinical significance in human epithelial ovarian cancer [J]. Tumor, 2006,26(9):851-855. [in Chinese]
9. Scotton CJ, Wilson JL, Scott K, et al. Multiple actions of the chemokine CXCL12 on epithelial tumor cells in human ovarian cancer [J]. Cancer Res, 2002,62(20):5930-5938.
10. Lu DY, Tang CH, Yeh WL, et al. SDF-1 alpha up-regulates interleukin-6 through CXCR4, P13K/Akt, ERk, and NF-kappa B-dependent pathway in microglia [J]. Eur J Pharmacol, 2009,613(1-3):146-154.
11. Burger JA, Kipps TJ. CXCR4: a key receptor in the crosstalk between tumor cells and their microenvironment [J]. Blood, 2006, 107(5):1761-1767.
12. Baggiolini M. Chemokines and leukocyte traffic [J]. Nature, 1998, 392(6676):565-568.
13. Hall JM, Korach KS. Stromal cell-derived factor-1, a novel target of estrogen receptor action, mediates the mitogenic effects of estradiol in ovarian and breast cancer cells [J]. Mol Endocrinol, 2003,17(5):792-803.
14. Deng L, Chen N, Li Y, et al. CXCR6/CXCL16 functions as a regulator in metastasis and progression of cancer [J]. Biochim Biophys Acta, 2010,1806(1):42-49.
15. Meijer J, Ogink J, Kreike B, et al. The chemokine receptor CXCR6 and its ligand CXCL16 are expressed in carcinomas and inhibit proliferation [J]. Cancer Res, 2008,68 (12):4701-4708.
16. Wang J, Lu Y, Wang J, et al. CXCR6 induces prostate cancer progression by the AKT/Mammalian target of rapamycin signaling pathway [J]. Cancer Res, 2008,68(24):10367-10376.